JAN (NYSE:JAN) Stock Rated “Moderate Buy” by Wall Street Analysts

Shares of JAN (NYSE:JAN) have earned an average recommendation of “Moderate Buy” from the seventeen ratings firms that are covering the stock, Marketbeat reports. Four research analysts have rated the stock with a hold recommendation, twelve have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $32.31.

Several research analysts recently issued reports on JAN shares. Morgan Stanley increased their price objective on JAN from $28.00 to $31.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 18th. Wells Fargo & Company decreased their target price on JAN from $35.00 to $34.00 and set an “overweight” rating for the company in a research report on Monday, October 19th. Cantor Fitzgerald upped their target price on JAN from $30.00 to $34.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Barclays dropped their price target on JAN from $34.00 to $33.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 13th. Finally, Compass Point began coverage on JAN in a research note on Wednesday, September 16th. They set a “neutral” rating and a $37.00 price target on the stock.

JAN Stock Up 0.1%

Shares of NYSE:JAN opened at $28.54 on Friday. The firm’s 50 day simple moving average is $29.68 and its 200-day simple moving average is $28.02. JAN has a one year low of $22.76 and a one year high of $32.83.

JAN (NYSE:JAN) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.18). The firm had revenue of $216.46 million for the quarter, compared to analysts’ expectations of $203.32 million. The firm’s quarterly revenue was up 45.4% on a year-over-year basis. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. As a group, equities analysts expect that JAN will post 0.97 earnings per share for the current year.

JAN Dividend Announcement

The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, December 29th. Investors of record on Friday, December 18th will be paid a $0.0475 dividend. The ex-dividend date of this dividend is Friday, December 18th. This represents a $0.57 dividend on an annualized basis and a yield of 2.0%.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. Nisa Investment Advisors LLC bought a new stake in shares of JAN in the 3rd quarter valued at about $27,000. State of Wyoming lifted its position in shares of JAN by 258.7% in the 3rd quarter. State of Wyoming now owns 4,814 shares of the company’s stock worth $143,000 after purchasing an additional 3,472 shares during the period. State of Alaska Department of Revenue boosted its stake in shares of JAN by 57.6% during the third quarter. State of Alaska Department of Revenue now owns 36,557 shares of the company’s stock valued at $1,082,000 after purchasing an additional 13,367 shares in the last quarter. Inspire Investing LLC bought a new position in shares of JAN during the third quarter valued at approximately $484,000. Finally, Greenland Capital Management LP bought a new position in shares of JAN during the second quarter valued at approximately $575,000. Hedge funds and other institutional investors own 6.27% of the company’s stock.

JAN News Roundup

Here are the key news stories impacting JAN this week:

• Neutral Sentiment: The most recent quarterly update remains the primary fundamental reference: JAN reported revenue of $216.5 million, up 45.4% year over year and above analyst expectations, but earnings per share of $0.05 missed consensus by $0.18.
• Neutral Sentiment: Management’s fiscal 2026 EPS guidance remains $0.95–$0.98, broadly in line with the sell-side estimate of $0.97. Investors may continue looking for evidence that earnings can improve after the latest quarterly miss.
• Neutral Sentiment: Trading volume was approximately 2.9 million shares, nearly twice the average, suggesting elevated activity despite the lack of a clearly identified JAN-specific catalyst.

JAN Company Profile

JanOne Inc (NYSE: JAN) is a social-impact and technology company focused on addressing the opioid crisis. Its activities have included the development and commercialization of solutions intended to support opioid-related treatment and prevention, with an emphasis on using business and technology to promote measurable social benefits.

Through its subsidiaries and related operations, JanOne has also pursued financial technology initiatives, including blockchain-based payment and transaction solutions.